Clinical Trial Update: Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on desvenlafaxine for treating hot flashes in women with breast cancer on tamoxifen; study status terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms
• Hot Flashes

Drugs mentioned

• Desvenlafaxine (Desvenlafaxine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hot Flashes, Breast Neoplasms | Phase 4 | Status: TERMINATED